Mirion (MIR) Q3 2026 Earnings Call Transcript

Mirion Technologies reported Q3 revenue of $277.8 million, up 24.5% year over year, while core orders rose 62% to $340 million and backlog reached $1.25 billion. The company raised 2026 revenue-growth guidance to 24%–25% and organic-growth guidance to 7%–8%; adjusted free-cash-flow guidance also increased to $170 million–$185 million. Management withdrew its prior 2028 margin target as it invests in AI and cybersecurity and cited Paragon margin pressure, while reaffirming a commitment to annual margin expansion. Mirion completed its initial $100 million repurchase authorization and has $235 million remaining under a new $250 million program.

Analysis

MIR’s strongest evidence is shifting from nuclear-cycle narrative to conversion: installed-fleet work can support demand without relying on newbuild schedules, while rising near-term backlog offers a measurable test of execution. That makes the setup more durable than an SMR-led thesis—but quarterly orders remain lumpy, and backlog is not equivalent to profitable revenue.

The key debate is growth quality. Management is accepting near-term margin drag from Paragon development and AI/cyber investment in exchange for future capability; returns on that spend are not yet quantified. With the prior margin target withdrawn, investors should underwrite growth and margin separately rather than assume operating leverage will automatically follow. Inflation appears manageable on newly signed large contracts, but older backlog and project-level costs warrant scrutiny.

Near term, the Q4 acceleration is the execution catalyst; a miss could expose the gap between order momentum and recognized revenue. Over 1–3 months, monitor conversion, segment margins and year-end leverage. Over 6–18 months, life extensions, uprates and digital upgrades could broaden the installed-base opportunity, while EU funding remains a gating item for the French awards. The contrarian risk is that investors may over-credit headline order growth and underweight lumpiness, integration dilution and an unproven AI payoff. Conversely, treating nuclear demand as wholly dependent on newbuilds may understate the installed-fleet runway.

Key Decisions for Investors

• Construct a modest long MIR on weakness rather than chase the order-growth headline; add only if Q4 organic growth accelerates as guided and backlog converts on schedule. No valuation or share-price data is supplied, so size against the portfolio’s existing nuclear exposure.
• Use the next results to test growth quality: track nuclear-and-safety margin recovery, Paragon project-development costs, and cash conversion. Reassess if conversion disappoints or margins keep deteriorating despite higher revenue.
• Do not treat the remaining buyback authorization as a near-term floor: the stated year-end leverage objective assumes no Q4 repurchases or M&A. Watch actual leverage and cash generation before underwriting buybacks as a material per-share catalyst.
• Keep the French EDF awards as a catalyst watch, not booked revenue, until EU funding approval is formal. A delay would defer the associated order/backlog contribution; approval would strengthen forward visibility.